MON-429 The TSH Receptor Antibody Reactome Determines Thyroid and Retroorbital Responsiveness

Abstract Disclosure: P. xiang: None. R. Latif: None. T.F. Davies: None. The relative role of the different TSH receptor antibodies generated in patients with Graves’ disease remains unclear. Several animal models of Graves' disease (GD) and thyroid eye disease (TED) have been reported in response to immunization with different forms of TSH receptor (TSHR) antigen and should have helped clarify this immunopathology. However, these animal models remain insufficiently robust and continue to fall short in fully replicating the complexities of the human disease with its mixture of stimulating, blocking and neutral TSH receptor antibodies. In this study, we further evaluated a mouse model of GD and the role of TSHR antibodies of differing bioactivity. Balb/c mice were immunized with an IM injection of an adenovirus expressing residues 1-289 of the human TSHR (Ad-TSHR 289) (absent the hinge region) or control vector (Ad-Lacz) with 10 injections at 3-week intervals. Thyroid function was assessed by total thyroxine (T4) and TSH levels. The presence of TSHR binding antibodies as well as stimulating TSHR antibodies (TSAb), and TSH-blocking TSHR antibodies (TBAb) were evaluated using flow cytometry and a luciferase based cell bioassay. To further assess the induced changes we also carried out thyroid gland ultrasound and histology, and for eye changes we performed MRI scans along with histological examination of the eyes at 30 weeks. Out of 16 mice, 9 became hyperthyroid - characterized by decreased TSH levels, increased T4 levels, and diffuse enlargement of the thyroid glands. All mice developed TSHR antibodies when assessed by flow cytometry. 8/9 of the hyperthyroid mice had detectable TSAb of low levels when compared to that obtained with TSH ligand and control TSAb. Seven additional mice showed detectable TBAb only and only 2 mice had detectable linear antibodies to the TSHR. Five hyperthyroid mice showed eye signs, including conjunctival redness and eyelid thickening. MRI scans and histological staining revealed mild enlargement of retrobulbar adipose tissue and retro-orbital muscle accompanied by a macrophage infiltration. Hyperthyroidism was only found in 9/16 (56%) of mice despite all mice expressing TSHR antibodies. The TSAbs detected were of a low level and in their presence we could not detect TBAb in these mice although such blocking antibodies may have developed simultaneously explaining the low stimulating bioactivity. In support of this interpretation, additional mice developed detectable TBAb only - highly suggestive of their dampening any TSAb response and preventing the onset of hyperthyroidism. These multiple antibodies to TSHR antigen (the reactome) have to be considered in all immunization mouse models of GD since they are the ultimate determination of the thyroid response. Presentation: Monday, July 14, 2025

Institutions

Publication Details

Journal
Journal of the Endocrine Society
Published
2025-10-01
DOI
https://doi.org/10.1210/jendso/bvaf149.2202
Primary Topic
Ophthalmology and Eye Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

MON-429 The TSH Receptor Antibody Reactome Determines Thyroid and Retroorbital Responsiveness

Journal of the Endocrine Society
Ophthalmology and Eye Disorders
article

MON-429 The TSH Receptor Antibody Reactome Determines Thyroid and Retroorbital Responsiveness

article en

Abstract

Abstract Disclosure: P. xiang: None. R. Latif: None. T.F. Davies: None. The relative role of the different TSH receptor antibodies generated in patients with Graves’ disease remains unclear. Several animal models of Graves' disease (GD) and thyroid eye disease (TED) have been reported in response to immunization with different forms of TSH receptor (TSHR) antigen and should have helped clarify this immunopathology. However, these animal models remain insufficiently robust and continue to fall short in fully replicating the complexities of the human disease with its mixture of stimulating, blocking and neutral TSH receptor antibodies. In this study, we further evaluated a mouse model of GD and the role of TSHR antibodies of differing bioactivity. Balb/c mice were immunized with an IM injection of an adenovirus expressing residues 1-289 of the human TSHR (Ad-TSHR 289) (absent the hinge region) or control vector (Ad-Lacz) with 10 injections at 3-week intervals. Thyroid function was assessed by total thyroxine (T4) and TSH levels. The presence of TSHR binding antibodies as well as stimulating TSHR antibodies (TSAb), and TSH-blocking TSHR antibodies (TBAb) were evaluated using flow cytometry and a luciferase based cell bioassay. To further assess the induced changes we also carried out thyroid gland ultrasound and histology, and for eye changes we performed MRI scans along with histological examination of the eyes at 30 weeks. Out of 16 mice, 9 became hyperthyroid - characterized by decreased TSH levels, increased T4 levels, and diffuse enlargement of the thyroid glands. All mice developed TSHR antibodies when assessed by flow cytometry. 8/9 of the hyperthyroid mice had detectable TSAb of low levels when compared to that obtained with TSH ligand and control TSAb. Seven additional mice showed detectable TBAb only and only 2 mice had detectable linear antibodies to the TSHR. Five hyperthyroid mice showed eye signs, including conjunctival redness and eyelid thickening. MRI scans and histological staining revealed mild enlargement of retrobulbar adipose tissue and retro-orbital muscle accompanied by a macrophage infiltration. Hyperthyroidism was only found in 9/16 (56%) of mice despite all mice expressing TSHR antibodies. The TSAbs detected were of a low level and in their presence we could not detect TBAb in these mice although such blocking antibodies may have developed simultaneously explaining the low stimulating bioactivity. In support of this interpretation, additional mice developed detectable TBAb only - highly suggestive of their dampening any TSAb response and preventing the onset of hyperthyroidism. These multiple antibodies to TSHR antigen (the reactome) have to be considered in all immunization mouse models of GD since they are the ultimate determination of the thyroid response. Presentation: Monday, July 14, 2025

Journal of the Endocrine SocietyVol. 9(Supplement_1)
Icahn School of Medicine at Mount Sinai (US)
Good health and well-being
Openalex Percentile: Top 36%
Ophthalmology and Eye Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.